Stents with drug eluting coatings
The present invention relates generally to medical devices, preferably a stent, having a drug eluting surface coated or covered with a coating of particles comprising at least an outer layer, an inner layer, and a core comprising a therapeutic agent. Specifically, the invention relates to medical devices having a hydrophilic coating comprising particles with a hydrophilic outer layer, a hydrophobic inner layer, and a core comprising a hydrophobic therapeutic agent, as well as medical devices having a hydrophobic coating comprising particles with a hydrophobic outer layer, a hydrophilic inner layer, and a core comprising a hydrophilic therapeutic agent. The coating, outer layer, and inner layer are preferably biodegradable and capable of providing sustained release of the therapeutic agent over a time period. The invention also relates to methods of making and methods of using the coated or covered medical device.
1. A medical device comprising a surface and a coating disposed on the surface, wherein the coating comprises a first hydrophilic polymeric material incorporating a plurality of particles, and wherein the particles comprise an outer layer comprising a second hydrophilic polymeric material, an inner layer comprising a hydrophobic polymeric material, and a core comprising a hydrophobic therapeutic agent.
2. The medical device of claim 1 , wherein the particles comprise nanoparticles.
3. The medical device of claim 1 , wherein the first hydrophilic polymeric material is biodegradable.
4. The medical device of claim 1 , wherein the first hydrophilic polymeric material comprises polyvinyl alcohol (PVA) or poly(L-lactide) (PLLA).
5. The medical device of claim 1 , wherein the first and second hydrophilic polymeric materials are the same.
6. The medical device of claim 1 , wherein the outer layer of the particles is biodegradable.
7. The medical device of claim 1 , wherein the inner layer of the particles is biodegradable.
8. The medical device of claim 1 , wherein the medical device is a stent.
9. The medical device of claim 1 , wherein the coating is capable of providing sustained release of the therapeutic agent over a time period ranging from about 1 hour to about 2 years.
10. The medical device of claim 1 , wherein the therapeutic agent inhibits cell proliferation, contraction, migration or hyperactivity.
11. The medical device of claim 1 , wherein the therapeutic agent comprises paclitaxel.
12. The medical device of claim 1 , wherein the surface comprises a ceramic layer.
13. A method for treating stenosis or restenosis comprising inserting or implanting the medical device of claim 1 into a subject.
14. A medical device comprising a surface and a coating disposed on the surface, wherein the coating comprises a first hydrophilic, biodegradable polymeric material incorporating a plurality of nanoparticles, and wherein the nanoparticles comprise an outer layer comprising a second hydrophilic polymeric material, an inner layer comprising a hydrophobic polymeric material, and a core comprising paclitaxel.